Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro

Oncol Rep. 2004 Sep;12(3):659-62.

Abstract

This study was conducted to investigate the anti-proliferative activities of medicinal mushroom Ganoderma lucidum (Rei-shi or Mannentake). We have identified an alcohol extract from the spore of Ganoderma lucidum that inhibits the in vitro proliferation of human umbilical vein endothelial cells and MDA-MB231 human breast cancer cells. Further fractionation of the alcohol extract revealed that the ethyl acetate fraction inhibited both cell lines in a dose-dependent manner from 2 to 40 micro g/ml. Our results suggest that the alcohol extract from the spore of Ganoderma lucidum may possess potential anti-tumor and anti-angiogenic activities.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Cell Division
  • Cell Line, Tumor
  • Cells, Cultured
  • Chromatography
  • Dose-Response Relationship, Drug
  • Drugs, Chinese Herbal / therapeutic use*
  • Endothelial Cells / cytology
  • Ethanol / pharmacology
  • Humans
  • In Vitro Techniques
  • Plant Extracts / therapeutic use*
  • Reishi / metabolism*
  • Spores, Fungal / metabolism
  • Umbilical Veins / cytology

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Drugs, Chinese Herbal
  • Plant Extracts
  • Ethanol